An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload

Carcinogenesis

Volumn 20, Issue 9, 1999, Pages 1801-1807

  Chen, Xiaoxin ^a   Yang, Guang Yu ^a   Ding, Wei Yu ^a   Bondoc, Flordeliza ^a   Curtis, Stephen K ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; HEMOGLOBIN; IRON; IRON DEXTRAN; RETINOL; SERUM ALBUMIN; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER RISK; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DUODENOGASTRIC REFLUX; DUODENUM; EPITHELIUM DYSPLASIA; ESOPHAGITIS; ESOPHAGUS ANASTOMOSIS; ESOPHAGUS CARCINOMA; FOOD INTAKE; HEMOGLOBIN DETERMINATION; IRON BLOOD LEVEL; IRON INTAKE; IRON THERAPY; LOWER ESOPHAGUS SPHINCTER; MALE; MUCINOUS CARCINOMA; PRIORITY JOURNAL; RAT; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TRANSFERRIN BLOOD LEVEL;

ADENOCARCINOMA, MUCINOUS; ANASTOMOSIS, SURGICAL; ANIMALS; BARRETT ESOPHAGUS; COCARCINOGENESIS; DISEASE MODELS, ANIMAL; DUODENUM; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL CONTENTS; INJECTIONS, INTRAPERITONEAL; IRON; IRON OVERLOAD; IRON-DEXTRAN COMPLEX; MALE; METAPLASIA; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; STOMACH; TRANSFERRIN; VITAMIN A; VITAMIN E;

EID: 0032823595     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.9.1801     Document Type: Article

References (42)

1. Altorki, N.K., Oliveria, S. and Schrump, D.S. (1997) Epidemiology and molecular biology of Barrett's adenocarcinoma. Sem. Surg. Oncol., 13, 270-280.
2. Blot, W.J., Devesa, S.S. and Fraumeni, J.F. (1993) Continuing climb in rates of esophageal adenocarcinoma: an update. J. Am. Med. Assoc., 270, 1320.
3. Zhang, Z.-F., Kurtz, R.C., Sun, M., Karpeh, M., Yu, G.-P., Gargon N., Fein, J.S., Georgopoulos, S.K. and Harlap, S. (1996) Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol and socioeconomic factors. Cancer Epidemiol. Biomarkers Prev., 5, 761-768.
4. Farrow, D.C. and Vaughan, T.L. (1996) Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control, 7, 332-327.
5. Corder, A.P., Jones, R.H., Sadler, G.H., Daniels, P. and Johnson, C.D. (1996) Heartburn, esophagitis and Barrett's esophagus in self-medicating patients in general practice. Br. J. Clin. Pract., 50, 245-248.
6. Heading, R.C. (1989) Epidemiology of esophageal reflux disease. Scand. J. Gastroenterol., 168 (Suppl.), 33-37.
7. Kay, L., Jorgensen, T. and Jensen, K.H. (1994) Epidemiology of abdominal symptoms in a random population: prevalence, incidence and natural history. Eur. J. Epidemiol., 10, 559-566.
8. Isolauri, J., Luostarinen, M., Isolauri, E., Reinikainen, P. and Viljakka, M. (1997) Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am. J. Gastroenterol., 92, 37-41.
9. Cameron, A.J., Ott, B.J. and Payne, W.S. (1990) Prevalence of columnarlined (Barrett's) esophagus. Gastroenterology, 103, 1241-1245.
10. Cameron, A.J. (1997) Barrett's esophagus: Does the incidence of adenocarcinoma matter? Am. J. Gastroenterol., 92, 193-194.
11. Mirvish, S.S. (1997) Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma. Cancer Lett., 117, 161-174.
12. Attwood, S.E., Smyrk, T.C, DeMeester, T.R., Mirvish, S.S., Stein, H.J. and Hinder, R.A. (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery, 111, 503-510.
13. Miwa, K., Sahara, H., Segawa, M., Kinami, S., Sato, T., Miyazaki, I. and Hattori, T. (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int. J. Cancer, 67, 269-274.
14. Lambert, R. (1962) Relative importance of biliary and pancreatic secretions in the esophagitis in rats. Am. J. Dig. Dis., 7, 1026-1033.
15. Pera, M., Trastek, V.F., Carpenter, H.A., Fernandez, P.L., Cardesa, A., Mohr, U. and Pairolero, P.C. (1993) Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann. Thorac. Surg., 55, 1386-1393.
16. Goldstein, S.R., Yang, G.-Y., Curtis, S.K., Reuhl, K.R., Liu, B.-C., Mirvish, S.S., Newmark, H.L. and Yang, C.S. (1997) Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis, 18, 2265-2270.
17. Clark, G.W.B., Smyrk, T.C., Mirvish, S.S., Anselmino, M., Yamashita, Y., Hinder, R.A., DeMeester, T.R. and Birt, D.F. (1994) Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann. Surg. Oncol., 1, 252-261.
18. Pera, M., Cardesa, A., Bombi, J.A., Ernst, H., Pera, C. and Mohr, U. (1989) Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Res., 49, 6803-6808.
19. Goldstein, S.R., Yang, G.-Y., Chen, X., Curtis, S.K. and Yang, C.S. (1998) Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis, 19, 1445-1449.
20. Lewin, K.J. and Appelman, H.D. (1995) Barrett's esophagus, columnar dysplasia and adenocarcinoma of the esophagus. In Lewin, K.J. and Appelman, H.D. (eds) Tumors of the Esophagus and Stomach. AFIP, Washington, DC, pp. 99-144.
21. Yang, C.S. and Newmark, H. (1987) The roles of micronutrient deficiency in carcinogenesis. In David, S. (ed.) CRC Critical Reviews in Oncology/Hematology. Boca Raton, CRC Pres, Vol. 7, pp. 267-287.
22. Reeves, P.G., Nielsen, F.H. and Fahey, G.C.Jr (1993) AIN93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc Writing Committee on the reformulation of the AIN76A rodent diet. J. Nutr., 123, 1939-1951.
23. Sowell, A.L., Huff, D.L., Yeager, P.R., Caudill, S.P. and Gunter, E.W. (1994) Retinol, α-tocopherol, lutein/zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, trans-β-carotene and four retinyl esters in serum determining simultaneously by reverse phase HPLC with multilength detection. Clin. Chem., 40, 411-416.
24. Filipe, M.I. (1993). Malignant and inflammatory diseases of the gastrointestinal tract. In Filipe, M.I. and Lake B.D. (eds) Histochemistry in Pathology. Churchill Livingstone, New York, pp. 126-135.
25. Nguyen-Legros, J., Bizot, J., Bolesse, M. and Pulicani, J.P. (1980) Diaminobenzidine black as a new histochemical demonstration of exogenous iron. Histochemistry, 66, 239-244.
26. Herbst, J.J., Berenson, M.M., McClosky, D. and Wiser, W.C. (1978) Cell proliferation in esophageal columnar epithelium. Gastroenterology, 75, 683-687.
27. Vaezi, M.F., Singh, W. and Richter, J.E. (1995) Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology, 108, 1897-1907.
28. Kauer, W.H., Peters, J.H., DeMeester, T.R., Ireland, A.P., Bremner, C.G. and Hagen, J.A. (1995) Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. Ann. Surg., 222, 525-533.
29. Sumiyoshi, H., Yasui, W., Ochiai, A. and Tahara, E. (1984) Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res., 44, 4276-4280.
30. Vannieuwenhove, Y., Debacker, T., Chen, D., Hakanson, R. and Willems, G. (1998) Gastrin stimulates epithelial cell proliferation in the esophagus of rats. Virch. Arch., 434, 371-375.
31. Morris, C.J., Earl, J.R., Trenam, C.W. and Blake, D.R. (1995) Reactive oxygen species and iron - a dangerous partnership in inflammation. Int. J. Biochem. Cell Biol., 27, 109-122.
32. Weinberg, E.D. (1992) Roles of iron in neoplasia: promotion, prevention and therapy. Biol. Trace Element Res., 34, 123-140.
33. Torti, S.V. and Torti, F.M. (1994) Iron and ferritin in inflammation and cancer. Adv. Inorg. Biochem., 10, 119-137.
34. Knekt, P., Reunanen, H., Takkunen, H., Aroma, A., Heliovaara, M. and Hakulinen, T (1994) Body iron stores and risk of cancer. Int. J. Cancer, 56, 379-382.
35. Camhi, S.L., Lee, P. and Choi, A.M.K. (1995) The oxidative stress response. New Horizons, 3, 170-182.
36. Suzuki, K., Twardowski, Z.J., Nolph, K.D., Khanna, R. and Moore, H.L. (1995) Absorption of iron dextran from the peritoneal cavity of rats. Adv. Periton. Dial., 11, 57-59.
37. Dabbagh, A.J., Trenam, C.W., Morris, C.J. and Blake, D.R. (1993) Iron in joint inflammation. Ann. Rheum. Dis., 52, 67-71.
38. Brown, L.M., Swanson, C.A., Gridley, G., Swanson, G.M., Schoenberg, J.B., Greenberg, R.S., Silverman, D.T., Pottern, L.M., Hayes, R.B., Schwartz, A.G., Liff, J.M., Fraumeni, J.F.Jr and Hoover, R.N. (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J. Natl Cancer Inst., 87, 104-109.
39. Zhang, Z.-F., Kurtz, R.C. and Marshall, J.R. (1997) Cigarette smoking and esophageal and gastric cardia adenocarcinoma. J. Natl Cancer Inst., 89, 1247-1249.
40. Wang, H.H., Hsieh, C.-C. and Antonioli, D.A. (1994) Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States). Cancer Causes Control, 5, 573-578.
41. Hsing, A.W., McLaughlin, J.K., Olsen, J.H., Mellemkjar, L., Wachholder, S. and Fraumeni, J.F. (1995) Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int. J. Cancer, 60, 160-162.
42. FEBS Life Sciences Research Office (1995) Third Report on Nutrition Monitoring in the United States: Volume 1. US Government Printing Office, Washington, DC.